Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMI:TSE International Medical Innovations Inc. -- Ignore unavailable to you. Want to Upgrade?

To: gg cox who wrote (44)	6/1/2004 9:34:02 AM
From: gg cox	Read Replies (1) \| Respond to of 66

IMI International Medical Innovations Inc. - Conference Call to Discuss Worldwide Licensing Agreement with McNeil Consumer Healthcare (J&J) - June 1, 2004 Tuesday June 1, 9:00 am ET TORONTO, June 1 /CNW/ - Notification of Conference Call event: IMI International Medical Innovations Inc. (TSX: IMI.) (AMEX: IME - News) Worldwide Licensing Agreement with McNeil Consumer Healthcare (J&J) to Market IMI's Cardiovascular Disease Test June 1, 2004, 10:00 AM ET To access the conference call, please dial (416) 640-4127 in Toronto, or 1-800-814-4860 elsewhere in North America. A live audio webcast will be available at www.imimedical.com or www.newswire.ca and subsequently archived on both sites. To access the replay via telephone, which will be available until June 8, 2004, please dial (416) 640-1917 or 1-877-289-8525 and enter the passcode 21051734. For a complete listing of upcoming and archived webcasts available through Canada NewsWire, please visit our events calendar at newswire.ca. CNW's webcast of earnings calls is consistent with Market Regulation Services Inc. (RS) initiatives to broaden investor access through the use of new technology. newswire.ca newswire.ca For further information